Bristol-Myers Squibb Company – Plans of Reorganization, Merger, Acquisition or Similar

NYSE: BMY
Share price (9/23/26): $61.15
Market cap (9/23/26): $125 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 123 pages Agreement and Plan of Merger Dated as of January 2, 2019 Among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc. and Celgene Corporation

from 8-K 123 pages Agreement and Plan of Merger Dated as of January 2, 2019 Among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc. and Celgene Corporation

from SC TO-C 87 pages Agreement and Plan of Merger by and Among Bristol-Myers Squibb Company, B&R Acquisition Company and Amylin Pharmaceuticals, Inc. Dated as of June 29, 2012

from 8-K 87 pages Agreement and Plan of Merger by and Among Bristol-Myers Squibb Company, B&R Acquisition Company and Amylin Pharmaceuticals, Inc. Dated as of June 29, 2012

from 8-K ~10 pages Amendment to Purchase Agreement